Table 2.
IP-10 based classification | Bacteriological status at diagnosis | All cases | Excluding cases with any drug resistance to HRZE# | ||||||
---|---|---|---|---|---|---|---|---|---|
Total cases* | n | (%) | p-value | Total cases | n | (%) | p-value | ||
Response to treatment | TB bacteriologically confirmed | 61 | 48 | 78.7 | 0.002 | 51 | 38 | 74.5 | 0.002 |
TB clinically diagnosed | 13 | 21.3 | 13 | 25.5 | |||||
Poor response to treatment | TB bacteriologically confirmed | 57 | 29 | 50.9 | 50 | 22 | 44.0 | ||
TB clinically diagnosed | 28 | 49.1 | 28 | 56.0 | |||||
Total | 118 | 101 |
*Some patients (n = 9) did not have D7 IP-10 data (including one Rif resistant case), thus were excluded in this table. #This analysis includes cases with streptomycin resistance and excludes 4 cases bacteriologically confirmed without MGIT-based drug susceptibility testing. H:Isoniazid; R: Rifampicin; Z: Pyrazinamide; E: Ethambutol.